Here's the short version. GHK-Cu, the copper peptide in a lot of skin serums, has never been tested in a published acne trial. The human skin studies that do exist are small, and a small randomized post-laser trial found no objective change [3]. If acne is the problem, the guideline-backed treatments are a better place to start [5].
Active acne: no trial has tested it
GHK-Cu hasn't been tested in a published randomized trial for acne. A PubMed search for "GHK-Cu acne" returned one record, a 2026 review, not a trial [6]. A broader search for "copper peptide acne" returned three records, and none was an acne trial.
That review screened 1,247 records on GHK-Cu and kept 64. Its summary: the preclinical work is deep, but the human literature is "thin and fragmented," with small trials mostly on facial cosmetic creams [2]. Acne isn't among the human results it reports.
So when a product page says a copper peptide "clears breakouts," there's no trial behind that line.
Acne scars and firmness: small studies, no clear win
Scars are a different question from active acne. A 40-person nonrandomized study compared dermaroller alone with dermaroller plus copper peptide. It found no significant later between-group benefit and reported more hyperpigmentation with the combination [1].
In that trial, patients had CO2 laser resurfacing around the mouth, then used a skin-care regimen with or without GHK-Cu. Thirteen people completed it. Blinded evaluators and computer analysis found no difference in redness, wrinkles or overall skin quality at 12 weeks. On a questionnaire, though, the GHK-Cu group rated their skin quality better (P = .04) [3].
That's a real finding, but a soft one: people felt their skin looked better, while the measurements didn't move. It also wasn't an acne-scar study. The 2026 review lists atrophic acne scarring as an area where well-designed trials are still needed [2]. Needed means not done yet.
| Claim | Human evidence found | Result | Strength of evidence |
|---|---|---|---|
| Clears active acne | None (PubMed search) | Not tested | No evidence |
| Fades acne scars | Small nonrandomized dermaroller comparison [1] | No significant later between-group benefit; pigmentation concern | Low |
| Improves wrinkles or skin quality | One randomized trial after laser resurfacing, 13 completers [3] | No objective difference at 12 weeks; users rated skin quality better | Low |
| Tightens loose skin | No controlled trial found | Not tested | No evidence |
| Calms rosacea or eczema | No controlled trial found | Not tested | No evidence |
"Low" means a single small trial. A PubMed search for GHK-Cu with rosacea or eczema returned no records.
Why copper peptides are marketed for skin anyway
Most GHK-Cu skin claims come from cell and animal studies of wound healing and collagen. A lot of that work traces back to one research group.
An overview was written by Loren Pickart, who first isolated the peptide [4]. It describes GHK's effects on skin-cell pathways in the lab. The 2026 review counts about 35% of the primary GHK-Cu papers in its window with Pickart or a colleague from his company as an author [2]. The reviewers say that concentration limits the evidence base.
Lab results are a reason to run a trial. They aren't the trial. For a fuller picture of what's been measured and when, see how long GHK-Cu takes to work.
What does work for acne
The American Academy of Dermatology's 2024 guideline makes strong recommendations for benzoyl peroxide, topical retinoids, topical antibiotics and oral doxycycline [5].
- Strongly recommended: benzoyl peroxide, topical retinoids, topical antibiotics, oral doxycycline.
- Strongly recommended for severe acne, acne causing psychosocial burden or scarring, or acne that hasn't responded to standard treatment: oral isotretinoin.
- Conditionally recommended: topical clascoterone, salicylic acid, azelaic acid, oral minocycline, sarecycline, combined oral contraceptive pills and spironolactone.
The guideline also calls combining topical treatments with different mechanisms good practice [5]. Which ones fit you is a call for a dermatologist or your prescriber, especially for the prescription-only options.
If you still want to try a copper-peptide product
Copper-peptide skin care is sold two ways: as a cosmetic you can buy off the shelf, or as a compounded topical a clinician prescribes. Tell your dermatologist before adding one, especially if you already use a retinoid or an acid.
A cosmetic doesn't need FDA approval before it's sold, as long as it makes no drug claims. FDA says claims to treat a disease or "regenerate cells" make a product a drug [7]. The non-injectable form of GHK-Cu is in Category 1 of FDA's 503A list, which may fall within FDA’s interim enforcement policy when all applicable conditions are met [8].
Among telehealth programs, AgelessRx, Eden and HealthRX list a compounded topical GHK-Cu cream or foam.
Injectable GHK-Cu is a different story. It has no legal compounding route in the US, as FDA's record on injectable GHK-Cu shows. If skin is your goal, the skin shortlist covers the options with a lawful route, and the 30-second match narrows it to your situation.
Rosacea and eczema: not tested either
No controlled trial of GHK-Cu for rosacea or eczema was found. A PubMed search for each returned no records [6].
Both conditions flare with the wrong product, and both have treatments a dermatologist can prescribe. Start there, and bring any serum you're thinking of adding so they can check the label.
Wondering about hair instead? The same pattern holds: related molecules were tested, GHK-Cu alone wasn't. See GHK-Cu for hair growth.